Suppr超能文献

2008 - 2012年中国肺癌的发病率和死亡率

Incidence and mortality of lung cancer in China, 20082012.

作者信息

Liu Shuzheng, Chen Qiong, Guo Lanwei, Cao Xiaoqin, Sun Xibin, Chen Wanqing, He Jie

机构信息

Henan Cancer Prevention and Control Office, Affiliated Tumor Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou 450008, China.

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100021, China.

出版信息

Chin J Cancer Res. 2018 Dec;30(6):580-587. doi: 10.21147/j.issn.1000-9604.2018.06.02.

Abstract

OBJECTIVE

To analyze the incidence and mortality rates of lung cancer in China from 2008 to 2012.

METHODS

Incident and death cases of lung cancer were retrieved from the National Central Cancer Registry (NCCR) database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of lung cancer were calculated by area (urban/rural), region (eastern, middle, western), gender and age group (0, 1-4, 5-9, …, 85+). China census in 2000 and Segi's world population were applied for age-standardized rates. JoinPoint (Version 4.5.0.1) model was used for time trend analysis.

RESULTS

The crude incidence rate of lung cancer was 54.66/100,000 which ranked the first in overall cancers. The age-standardized incidence rates by China population (ASIRC) and by World population (ASIRW) were 35.13/100,000 and 34.86/100,000, respectively. The crude mortality of lung cancer in China was 45.60/100,000 and it was the first cause of cancer-related death in overall cancers. The age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 28.57/100,000 and 28.22/100,000, respectively. Incidence and mortality rates of lung cancer were higher in males than in females and higher in urban areas than in rural areas. Eastern areas had the highest incidence and mortality rates followed by middle and western areas. Incidence and mortality rates of lung cancer retained low level in age groups before 40 years old but increased greatly after and peaked in age group of 80-84. During 2003-2012, the temporal trend of the incidence rate of lung cancer in both sexes in China was general stable (P<0.05). The lung cancer incidence rate increased by 0.71% per year in females (P<0.05) and 2.26% per year in rural areas (P<0.05). The mortality rate of lung cancer decreased slightly annually during 2003-2012 in China (P>0.05). In urban areas, it declined by 0.76% per year (P<0.05), but rose by 2.09% per year (P<0.05) in rural areas.

CONCLUSIONS

Appropriate targeted prevention, early detection and treatment programs should be carried out to control the local burden of lung cancer.

摘要

目的

分析2008年至2012年中国肺癌的发病率和死亡率。

方法

从国家中央癌症登记处(NCCR)数据库中检索2008 - 2012年期间中国135个癌症登记处收集的肺癌发病和死亡病例。按地区(城市/农村)、区域(东部、中部、西部)、性别和年龄组(0、1 - 4、5 - 9、…、85岁及以上)计算肺癌的粗发病率和死亡率。采用2000年中国人口普查数据和Segi世界人口数据计算年龄标准化率。使用JoinPoint(版本4.5.0.1)模型进行时间趋势分析。

结果

肺癌的粗发病率为54.66/10万,在所有癌症中排名第一。按中国人口计算的年龄标准化发病率(ASIRC)和按世界人口计算的年龄标准化发病率(ASIRW)分别为35.13/10万和34.86/10万。中国肺癌的粗死亡率为45.60/10万,是所有癌症相关死亡的首要原因。按中国标准人口计算的年龄标准化死亡率(ASMRC)和按世界标准人口计算的年龄标准化死亡率(ASMRW)分别为28.57/10万和28.22/10万。肺癌的发病率和死亡率男性高于女性,城市地区高于农村地区。东部地区的发病率和死亡率最高,其次是中部和西部地区。肺癌的发病率和死亡率在40岁以前的年龄组中保持在较低水平,但40岁以后大幅上升,并在80 - 84岁年龄组达到峰值。2003 - 2012年期间,中国男女肺癌发病率的时间趋势总体稳定(P<0.05)。女性肺癌发病率每年上升0.71%(P<0.05),农村地区每年上升2.26%(P<0.05)。中国2003 - 2012年期间肺癌死亡率每年略有下降(P>0.05)。在城市地区,每年下降0.76%(P<0.05),但在农村地区每年上升2.09%(P<0.05)。

结论

应开展适当的针对性预防、早期检测和治疗项目,以控制当地的肺癌负担。

相似文献

1
Incidence and mortality of lung cancer in China, 20082012.
Chin J Cancer Res. 2018 Dec;30(6):580-587. doi: 10.21147/j.issn.1000-9604.2018.06.02.
2
Incidence and mortality of laryngeal cancer in China, 2008-2012.
Chin J Cancer Res. 2018 Jun;30(3):299-306. doi: 10.21147/j.issn.1000-9604.2018.03.02.
3
Incidence and mortality of thyroid cancer in China, 20082012.
Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09.
4
Incidence and mortality of esophagus cancer in China, 20082012.
Chin J Cancer Res. 2019 Jun;31(3):426-434. doi: 10.21147/j.issn.1000-9604.2019.03.04.
5
National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
6
Report of incidence and mortality in China cancer registries, 2009.
Chin J Cancer Res. 2013 Feb;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04.
7
Incidence and mortality of cervical cancer in China in 2015.
J Natl Cancer Cent. 2022 Feb 3;2(2):70-77. doi: 10.1016/j.jncc.2022.01.002. eCollection 2022 Jun.
8
Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.
Chin J Cancer Res. 2017 Feb;29(1):1-10. doi: 10.21147/j.issn.1000-9604.2017.01.01.
9
[Incidence and mortality of endometrial cancer in China, data from China Cancer Registry Annual Report, 2004-2017].
Zhonghua Yi Xue Za Zhi. 2024 Mar 12;104(10):721-728. doi: 10.3760/cma.j.cn112137-20231017-00784.
10
[The incidence and mortality of lung cancer in China, 2014].
Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002.

引用本文的文献

2
Trends in Cancer Incidence and Potential Associated Factors in China.
JAMA Netw Open. 2024 Oct 1;7(10):e2440381. doi: 10.1001/jamanetworkopen.2024.40381.
3
Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening.
J Natl Cancer Cent. 2021 Jul 31;1(4):132-138. doi: 10.1016/j.jncc.2021.07.006. eCollection 2021 Dec.
6
[Recent Advances in Diagnosis and Treatment Strategies for Multiple Primary Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2023 Nov 20;26(11):863-873. doi: 10.3779/j.issn.1009-3419.2023.102.44.
7
The Increasing Burden of Cancer Among Women and in Rural Areas: A Retrospective Population-Based Study.
Inquiry. 2023 Jan-Dec;60:469580231195311. doi: 10.1177/00469580231195311.
8
Identifying the Environmental Determinants of Lung Cancer: A Case Study of Henan, China.
Geohealth. 2023 Jun 1;7(6):e2023GH000794. doi: 10.1029/2023GH000794. eCollection 2023 Jun.
9
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3209-3218. doi: 10.1007/s00432-022-04217-5. Epub 2022 Jul 29.
10
[Analysis on the Incidence and Economic Burden of Patients with Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2022 Mar 20;25(3):167-173. doi: 10.3779/j.issn.1009-3419.2022.101.09.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
The epidemiology of lung cancer.
Transl Lung Cancer Res. 2018 Jun;7(3):220-233. doi: 10.21037/tlcr.2018.05.06.
4
[Changing Epidemic of Lung Cancer & Tobacco and Situation of Tobacco Control 
in China].
Zhongguo Fei Ai Za Zhi. 2017 Aug 20;20(8):505-510. doi: 10.3779/j.issn.1009-3419.2017.08.01.
5
Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.
Chin J Cancer Res. 2017 Feb;29(1):1-10. doi: 10.21147/j.issn.1000-9604.2017.01.01.
6
Risk factors for lung cancer worldwide.
Eur Respir J. 2016 Sep;48(3):889-902. doi: 10.1183/13993003.00359-2016. Epub 2016 May 12.
7
National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
8
Lung cancer incidence and mortality in China, 2011.
Thorac Cancer. 2016 Jan;7(1):94-9. doi: 10.1111/1759-7714.12286. Epub 2015 Jun 26.
9
Lung Cancer Statistics.
Adv Exp Med Biol. 2016;893:1-19. doi: 10.1007/978-3-319-24223-1_1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验